Collegium Pharmaceutical, Inc. Common Stock
$22.19
$0.35 (+1.60%)
$21.68Day Range$22.80
Key Statistics
Market Cap
$711.01M
Shares Outstanding
32.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 7, 2015
Round Lot
100
Locale
US
Trading Data
Day Open
$21.84
Day High
$22.80
Day Low
$21.68
Volume
1.15M
VWAP
$22.23
Prev Close
$21.84
Transactions
--
Acc. Volume
--
About Collegium Pharmaceutical, Inc. Common Stock
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
PHARMACEUTICAL PREPARATIONSSIC 2834423 employees100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072781-713-3699IPO May 7, 2015US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001267565
- Composite FIGI
- BBG000N7LPW4
- Share Class FIGI
- BBG001T535S9
- Ticker Root
- COLL
- SIC Code
- 2834
About Collegium Pharmaceutical, Inc. Common Stock (COLL) Stock
Collegium Pharmaceutical, Inc. Common Stock (COLL) closed the 2026-09-16 session at $22.19, up 1.60% versus the previous close (+0.35). The stock opened at $21.84 and traded between $21.68 and $22.80 during that session. Session trading volume was 1.2M shares. The volume-weighted average price (VWAP) is $22.23.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
Collegium Pharmaceutical, Inc. Common Stock has a market capitalization of $711.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. COLL is listed on the XNAS exchange. The company employs approximately 423 people. Collegium Pharmaceutical, Inc. Common Stock is headquartered in STOUGHTON, MA. The recorded listing date is 2015-05-07.
On this page you can find market COLL stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.